https://www.markettradingessentials.com/2020/11/growth-investors-industry-analysts-just-upgraded-their-immunogen-inc-nasdaqimgn-revenue-forecasts-by-22/
Growth Investors: Industry Analysts Just Upgraded Their ImmunoGen, Inc. (NASDAQ:IMGN) Revenue Forecasts By 22%